Avonex 15 Year Long Term Follow-up Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The Avonex Fifteen-year Long-term Follow-up of Patients with Relapsing Multiple Sclerosis: ASSessment of Drug Utilization, EaRly TreAtmeNt, and Clinical OutcomEs (ASSURANCE), was a single-time-point evaluation of patients conducted 15 years after the pivotal MSCRG study, evaluated the impact of IM IFNβ-1a treatment on long-term disability and Quality of Life outcomes in patients who completed 2 years in a previous Multiple Sclerosis Collaborative Research Group (MSCRG) study.
Epistemonikos ID: 991ecd714d183e86fe59a875f420b1939cc04c80
First added on: May 04, 2024